Horizon Investment Services’s Charles River Laboratories CRL Stock Holding History

Horizon Investment Services’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-957	Closed	-$272K	–	102
2022 Q1	$272K	Sell	957 -6,432	-87%	-$1.98M	0.14%	99
2021 Q4	$2.78M	Sell	7,389 -5,789	-44%	-$2.25M	1.27%	22
2021 Q3	$5.44M	Sell	13,178 -93	-0.7%	-$38.6K	2.68%	9
2021 Q2	$4.91M	Buy	13,271 +116	+0.9%	+$38.7K	2.41%	11
2021 Q1	$3.81M	Buy	13,155 +5	+0%	+$1.39K	2.05%	14
2020 Q4	$3.29M	Sell	13,150 -404	-3%	-$96.2K	2%	15
2020 Q3	$3.07M	Sell	13,554 -323	-2%	-$67K	2.04%	13
2020 Q2	$2.42M	Buy	13,877 +1,931	+16%	+$308K	1.68%	20
2020 Q1	$1.51M	Buy	+11,946	New	+$1.79M	1.34%	26

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Horizon Investment Services's CRL Position: Q2 2022 in Review

Horizon Investment Services sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 957 shares — an estimated $272K sold.

Horizon Investment Services first reported a position in CRL in Q1 2020 and held it in 9 quarters. The position peaked at $5.44M in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

Horizon Investment Services reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
Horizon Investment Services sold 957 Charles River Laboratories shares in Q2 2022, an estimated $272K.
Horizon Investment Services first reported a position in Charles River Laboratories in Q1 2020 and held it in 9 quarters.
Horizon Investment Services's Charles River Laboratories position peaked at $5.44M in Q3 2021.
627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Horizon Investment Services's 13F filing for Q2 2022, filed 11 Aug 2022.